Ann Mosegaard BakSummaryAffiliation: University of Aarhus Country: Denmark |
Detail Information
Publications
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetesAnn Mosegaard Bak
University Hospital of Aarhus, Department of Medical Endocrinology, MEA, Nørrebrogade, Denmark
Expert Opin Ther Targets 15:1153-62. 2011..GLP-1 analogues may therefore be the new therapeutic agent of choice for intervention in AD...
